An important long-term goal would be a comparison of the methylation and transcription profiles of tumor models of less common but physiologically relevant IDH1 mutants, especially those we and others have shown to have distinct D2HG levels and kinetic profiles (20, 21, 22). The gene discussed is IDH1; the disease is neoplasm.